-
1
-
-
0027423378
-
Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure
-
The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators.
-
The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 1993 342 (8875 821 8.
-
(1993)
Lancet
, vol.342
, Issue.8875
, pp. 821-8
-
-
-
2
-
-
0028273258
-
GISSI-3: Effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction
-
Gruppo Italiano per lo Studio della Sopravvivenza nell'infarto Miocardico.
-
Gruppo Italiano per lo Studio della Sopravvivenza nell'infarto Miocardico. GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Lancet 1994 343 (8906 1115 22.
-
(1994)
Lancet
, vol.343
, Issue.8906
, pp. 1115-22
-
-
-
3
-
-
0028932732
-
ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction
-
ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group.
-
ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. Lancet 1995 345 (8951 669 85.
-
(1995)
Lancet
, vol.345
, Issue.8951
, pp. 669-85
-
-
-
4
-
-
0026786643
-
Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. the SAVE Investigators
-
Pfeffer MA, Braunwald E, Moye LA, Basta L, Brown EJ Jr., Cuddy TE, Davis BR, Geltman EM, Goldman S, Flaker GC. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N. Engl. J Med 1992 327 : 669 77.
-
(1992)
N. Engl. J Med
, vol.327
, pp. 669-77
-
-
Pfeffer, M.A.1
Braunwald, E.2
Moye, L.A.3
Basta, L.4
Brown Jr., E.J.5
Cuddy, T.E.6
Davis, B.R.7
Geltman, E.M.8
Goldman, S.9
Flaker, G.C.10
-
5
-
-
9044239676
-
A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group
-
Kober L, Torp-Pedersen C, Carlsen JE, Bagger H, Eliasen P, Lyngborg K, Videbaek J, Cole DS, Auclert L, Pauly NC. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group. N Engl J Med 1995 333 : 1670 6.
-
(1995)
N Engl J Med
, vol.333
, pp. 1670-6
-
-
Kober, L.1
Torp-Pedersen, C.2
Carlsen, J.E.3
Bagger, H.4
Eliasen, P.5
Lyngborg, K.6
Videbaek, J.7
Cole, D.S.8
Auclert, L.9
Pauly, N.C.10
-
6
-
-
0028961295
-
Oral captopril versus placebo among 13 634 patients with suspected acute myocardial infarction: Interim report from the Chinese Cardiac Study (CCS-1)
-
Oral captopril versus placebo among 13 634 patients with suspected acute myocardial infarction: interim report from the Chinese Cardiac Study (CCS-1). Lancet 1995 345 (8951 686 7.
-
(1995)
Lancet
, vol.345
, Issue.8951
, pp. 686-7
-
-
-
7
-
-
0028229094
-
Comparison of enalapril versus captopril on left ventricular function and survival three months after acute myocardial infarction (the 'PRACTICAL' study)
-
Foy SG, Crozier IG, Turner JG, Richards AM, Frampton CM, Nicholls MG, Ikram H. Comparison of enalapril versus captopril on left ventricular function and survival three months after acute myocardial infarction (the 'PRACTICAL' study). Am J Cardiol 1994 73 : 1180 6.
-
(1994)
Am J Cardiol
, vol.73
, pp. 1180-6
-
-
Foy, S.G.1
Crozier, I.G.2
Turner, J.G.3
Richards, A.M.4
Frampton, C.M.5
Nicholls, M.G.6
Ikram, H.7
-
8
-
-
0034688194
-
Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. the Heart Outcomes Prevention Evaluation Study Investigators
-
Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000 342 : 145 53.
-
(2000)
N Engl J Med
, vol.342
, pp. 145-53
-
-
Yusuf, S.1
Sleight, P.2
Pogue, J.3
Bosch, J.4
Davies, R.5
Dagenais, G.6
-
9
-
-
0042330455
-
Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: Randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study)
-
Fox KM. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet 2003 362 (9386 782 8.
-
(2003)
Lancet
, vol.362
, Issue.9386
, pp. 782-8
-
-
Fox, K.M.1
-
10
-
-
19644400972
-
Angiotensin-converting-enzyme inhibition in stable coronary artery disease
-
Braunwald E, Domanski MJ, Fowler SE, Geller NL, Gersh BJ, Hsia J, Pfeffer MA, Rice MM, Rosenberg YD, Rouleau JL. Angiotensin-converting-enzyme inhibition in stable coronary artery disease. N Engl J Med 2004 351 : 2058 68.
-
(2004)
N Engl J Med
, vol.351
, pp. 2058-68
-
-
Braunwald, E.1
Domanski, M.J.2
Fowler, S.E.3
Geller, N.L.4
Gersh, B.J.5
Hsia, J.6
Pfeffer, M.A.7
Rice, M.M.8
Rosenberg, Y.D.9
Rouleau, J.L.10
-
11
-
-
0037296498
-
The validity of the diagnosis of acute myocardial infarction in routine statistics: A comparison of mortality and hospital discharge data with the Danish MONICA registry
-
Madsen M, Davidsen M, Rasmussen S, Abildstrom SZ, Osler M. The validity of the diagnosis of acute myocardial infarction in routine statistics: a comparison of mortality and hospital discharge data with the Danish MONICA registry. J Clin Epidemiol 2003 56 : 124 30.
-
(2003)
J Clin Epidemiol
, vol.56
, pp. 124-30
-
-
Madsen, M.1
Davidsen, M.2
Rasmussen, S.3
Abildstrom, S.Z.4
Osler, M.5
-
12
-
-
18644362319
-
Nationwide trends in the prescription of beta-blockers and angiotensin-converting enzyme inhibitors after myocardial infarction in Denmark, 1995-2002
-
Gislason GH, Abildstrom SZ, Rasmussen JN, Rasmussen S, Buch P, Gustafsson I, Friberg J, Gadsboll N, Kober L, Stender S, Madsen M, Torp-Pedersen C. Nationwide trends in the prescription of beta-blockers and angiotensin- converting enzyme inhibitors after myocardial infarction in Denmark, 1995-2002. Scand Cardiovasc J 2005 39 : 42 9.
-
(2005)
Scand Cardiovasc J
, vol.39
, pp. 42-9
-
-
Gislason, G.H.1
Abildstrom, S.Z.2
Rasmussen, J.N.3
Rasmussen, S.4
Buch, P.5
Gustafsson, I.6
Friberg, J.7
Gadsboll, N.8
Kober, L.9
Stender, S.10
Madsen, M.11
Torp-Pedersen, C.12
-
13
-
-
0031003006
-
Use of sumatriptan in Denmark in 1994-5: An epidemiological analysis of nationwide prescription data
-
Gaist D, Andersen M, Aarup AL, Hallas J, Gram LF. Use of sumatriptan in Denmark in 1994-5: an epidemiological analysis of nationwide prescription data. Br J Clin Pharmacol 1997 43 : 429 33.
-
(1997)
Br J Clin Pharmacol
, vol.43
, pp. 429-33
-
-
Gaist, D.1
Andersen, M.2
Aarup, A.L.3
Hallas, J.4
Gram, L.F.5
-
15
-
-
0035931272
-
Use of the statins in patients after acute myocardial infarction: Does evidence change practice?
-
Jackevicius CA, Anderson GM, Leiter L, Tu JV. Use of the statins in patients after acute myocardial infarction: does evidence change practice? Arch Intern Med 2001 161 : 183 8.
-
(2001)
Arch Intern Med
, vol.161
, pp. 183-8
-
-
Jackevicius, C.A.1
Anderson, G.M.2
Leiter, L.3
Tu, J.V.4
-
16
-
-
26644463417
-
Hospital variation in mortality after first acute myocardial infarction in Denmark from 1995 to 2002: Lower short-term and 1-year mortality in high-volume and specialized hospitals
-
Rasmussen S, Zwisler AD, Abildstrom SZ, Madsen JK, Madsen M. Hospital variation in mortality after first acute myocardial infarction in Denmark from 1995 to 2002: lower short-term and 1-year mortality in high-volume and specialized hospitals. Med Care 2005 43 : 970 8.
-
(2005)
Med Care
, vol.43
, pp. 970-8
-
-
Rasmussen, S.1
Zwisler, A.D.2
Abildstrom, S.Z.3
Madsen, J.K.4
Madsen, M.5
-
17
-
-
33646750506
-
Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarction
-
Gislason GH, Rasmussen JN, Abildstrom SZ, Gadsboll N, Buch P, Friberg J, Rasmussen S, Kober L, Stender S, Madsen M, Torp-Pedersen C. Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarction. Eur Heart J 2006 27 : 1153 8.
-
(2006)
Eur Heart J
, vol.27
, pp. 1153-8
-
-
Gislason, G.H.1
Rasmussen, J.N.2
Abildstrom, S.Z.3
Gadsboll, N.4
Buch, P.5
Friberg, J.6
Rasmussen, S.7
Kober, L.8
Stender, S.9
Madsen, M.10
Torp-Pedersen, C.11
-
18
-
-
4143126680
-
Expert consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease. the Task Force on ACE-inhibitors of the European Society of Cardiology
-
Lopez-Sendon J, Swedberg K, McMurray J, Tamargo J, Maggioni AP, Dargie H, Tendera M, Waagstein F, Kjekshus J, Lechat P, Torp-Pedersen C. Expert consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease. The Task Force on ACE-inhibitors of the European Society of Cardiology. Eur Heart J 2004 25 : 1454 70.
-
(2004)
Eur Heart J
, vol.25
, pp. 1454-70
-
-
Lopez-Sendon, J.1
Swedberg, K.2
McMurray, J.3
Tamargo, J.4
Maggioni, A.P.5
Dargie, H.6
Tendera, M.7
Waagstein, F.8
Kjekshus, J.9
Lechat, P.10
Torp-Pedersen, C.11
-
19
-
-
0025913812
-
Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure
-
The SOLVD Investigators.
-
The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991 325 : 293 302.
-
(1991)
N Engl J Med
, vol.325
, pp. 293-302
-
-
-
20
-
-
0025770138
-
A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure
-
Cohn JN, Johnson G, Ziesche S, Cobb F, Francis G, Tristani F, Smith R, Dunkman WB, Loeb H, Wong M. A comparison of enalapril with hydralazine- isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 1991 325 : 303 10.
-
(1991)
N Engl J Med
, vol.325
, pp. 303-10
-
-
Cohn, J.N.1
Johnson, G.2
Ziesche, S.3
Cobb, F.4
Francis, G.5
Tristani, F.6
Smith, R.7
Dunkman, W.B.8
Loeb, H.9
Wong, M.10
-
21
-
-
0027461552
-
ACE inhibitors for myocardial infarction and unstable angina
-
Yusuf S, Kostis JB, Pitt B. ACE inhibitors for myocardial infarction and unstable angina. Lancet 1993 341 (8848 829.
-
(1993)
Lancet
, vol.341
, Issue.8848
, pp. 829
-
-
Yusuf, S.1
Kostis, J.B.2
Pitt, B.3
-
22
-
-
0033534085
-
Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group
-
Packer M, Poole-Wilson PA, Armstrong PW, Cleland JG, Horowitz JD, Massie BM, Ryden L, Thygesen K, Uretsky BF. Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group. Circulation 1999 100 : 2312 8.
-
(1999)
Circulation
, vol.100
, pp. 2312-8
-
-
Packer, M.1
Poole-Wilson, P.A.2
Armstrong, P.W.3
Cleland, J.G.4
Horowitz, J.D.5
Massie, B.M.6
Ryden, L.7
Thygesen, K.8
Uretsky, B.F.9
-
23
-
-
0037036971
-
Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: The OPTIMAAL randomised trial. Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan
-
Dickstein K, Kjekshus J. Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan. Lancet 2002 360 (9335 752 60.
-
(2002)
Lancet
, vol.360
, Issue.9335
, pp. 752-60
-
-
Dickstein, K.1
Kjekshus, J.2
-
24
-
-
0034612118
-
Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: Randomised trial - The Losartan Heart Failure Survival Study ELITE II
-
Pitt B, Poole-Wilson PA, Segal R, Martinez FA, Dickstein K, Camm AJ, Konstam MA, Riegger G, Klinger GH, Neaton J, Sharma D, Thiyagarajan B. Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial - the Losartan Heart Failure Survival Study ELITE II. Lancet 2000 355 (9215 1582 7.
-
(2000)
Lancet
, vol.355
, Issue.9215
, pp. 1582-7
-
-
Pitt, B.1
Poole-Wilson, P.A.2
Segal, R.3
Martinez, F.A.4
Dickstein, K.5
Camm, A.J.6
Konstam, M.A.7
Riegger, G.8
Klinger, G.H.9
Neaton, J.10
Sharma, D.11
Thiyagarajan, B.12
-
25
-
-
0242490542
-
Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both
-
Valsartan in Acute Myocardial Infarction Trial Investigators.
-
Pfeffer MA, McMurray JJV, Velazquez EJ, Rouleau J-L, Kober L, Maggioni AP, Solomon SD, Swedberg K, Van de Werf F, White H, Leimberger JD, Henis M, Edwards S, Zelenkofske S, Sellers MA, Califf RM, the Valsartan in Acute Myocardial Infarction Trial Investigators. Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N Engl J Med 2003 349 : 1893 906.
-
(2003)
N Engl J Med
, vol.349
, pp. 1893-906
-
-
Pfeffer, M.A.1
McMurray, J.J.V.2
Velazquez, E.J.3
Rouleau, J.-L.4
Kober, L.5
Maggioni, A.P.6
Solomon, S.D.7
Swedberg, K.8
Van De Werf, F.9
White, H.10
Leimberger, J.D.11
Henis, M.12
Edwards, S.13
Zelenkofske, S.14
Sellers, M.A.15
Califf, R.M.16
-
26
-
-
33645024483
-
Treatment benefit by perindopril in patients with stable coronary artery disease at different levels of risk
-
Deckers JW, Goedhart DM, Boersma E, Briggs A, Bertrand M, Ferrari R, Remme WJ, Fox K, Simoons ML. Treatment benefit by perindopril in patients with stable coronary artery disease at different levels of risk. Eur Heart J 2006 27 : 796 801.
-
(2006)
Eur Heart J
, vol.27
, pp. 796-801
-
-
Deckers, J.W.1
Goedhart, D.M.2
Boersma, E.3
Briggs, A.4
Bertrand, M.5
Ferrari, R.6
Remme, W.J.7
Fox, K.8
Simoons, M.L.9
-
27
-
-
0010838455
-
Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: A systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group
-
Flather MD, Yusuf S, Kober L, Pfeffer M, Hall A, Murray G, Torp-Pedersen C, Ball S, Pogue J, Moye L, Braunwald E. Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group. Lancet 2000 355 (9215 1575 81.
-
(2000)
Lancet
, vol.355
, Issue.9215
, pp. 1575-81
-
-
Flather, M.D.1
Yusuf, S.2
Kober, L.3
Pfeffer, M.4
Hall, A.5
Murray, G.6
Torp-Pedersen, C.7
Ball, S.8
Pogue, J.9
Moye, L.10
Braunwald, E.11
-
28
-
-
85047171677
-
Mortality rates in elderly patients who take different angiotensin-converting enzyme inhibitors after acute myocardial infarction: A class effect?
-
Pilote L, Abrahamowicz M, Rodrigues E, Eisenberg MJ, Rahme E. Mortality rates in elderly patients who take different angiotensin-converting enzyme inhibitors after acute myocardial infarction: a class effect? Ann Intern Med 2004 141 : 102 12.
-
(2004)
Ann Intern Med
, vol.141
, pp. 102-12
-
-
Pilote, L.1
Abrahamowicz, M.2
Rodrigues, E.3
Eisenberg, M.J.4
Rahme, E.5
-
29
-
-
11844304275
-
Comparison of angiotensin-converting enzyme inhibitors in the treatment of congestive heart failure
-
Tu K, Mamdani M, Kopp A, Lee D. Comparison of angiotensin-converting enzyme inhibitors in the treatment of congestive heart failure. Am J Cardiol 2005 95 : 283 6.
-
(2005)
Am J Cardiol
, vol.95
, pp. 283-6
-
-
Tu, K.1
Mamdani, M.2
Kopp, A.3
Lee, D.4
-
30
-
-
18844439176
-
Changes in hospitalization rate and mortality after acute myocardial infarction in Denmark after diagnostic criteria and methods changed
-
Abildstrom SZ, Rasmussen S, Madsen M. Changes in hospitalization rate and mortality after acute myocardial infarction in Denmark after diagnostic criteria and methods changed. Eur Heart J 2005 26 : 990 5.
-
(2005)
Eur Heart J
, vol.26
, pp. 990-5
-
-
Abildstrom, S.Z.1
Rasmussen, S.2
Madsen, M.3
-
31
-
-
0031046049
-
The assessment of refill compliance using pharmacy records: Methods, validity, and applications
-
Steiner JF, Prochazka AV. The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol 1997 50 : 105 16.
-
(1997)
J Clin Epidemiol
, vol.50
, pp. 105-16
-
-
Steiner, J.F.1
Prochazka, A.V.2
-
32
-
-
0037239005
-
European healthcare policies for controlling drug expenditure
-
Ess SM, Schneeweiss S, Szucs TD. European healthcare policies for controlling drug expenditure. Pharmacoeconomics 2003 21 : 89 103.
-
(2003)
Pharmacoeconomics
, vol.21
, pp. 89-103
-
-
Ess, S.M.1
Schneeweiss, S.2
Szucs, T.D.3
-
33
-
-
0037232464
-
Management of acute myocardial infarction in patients presenting with ST-segment elevation. the Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology
-
Van de Werf F, Ardissino D, Betriu A, Cokkinos DV, Falk E, Fox KA, Julian D, Lengyel M, Neumann FJ, Ruzyllo W, Thygesen C, Underwood SR, Vahanian A, Verheugt FW, Wijns W. Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 2003 24 : 28 66.
-
(2003)
Eur Heart J
, vol.24
, pp. 28-66
-
-
Van De Werf, F.1
Ardissino, D.2
Betriu, A.3
Cokkinos, D.V.4
Falk, E.5
Fox, K.A.6
Julian, D.7
Lengyel, M.8
Neumann, F.J.9
Ruzyllo, W.10
Thygesen, C.11
Underwood, S.R.12
Vahanian, A.13
Verheugt, F.W.14
Wijns, W.15
|